ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1588

A Quality Improvement Project to Improve Bone Densitometry Ordering in Adult Patients on Chronic Glucocorticoids

Katherine Kaufman1, Philip Chu1, Mithu Maheswaranathan1, Andrew Johannemann1, D Ryan Anderson1, Isaac Smith1, Akrithi Udupa1, Mary Buckley1, Laura Cannon1, Rachel Randell1 and David Leverenz1, 1Duke University, DURHAM, NC

Meeting: ACR Convergence 2020

Keywords: Bone density, osteoporosis, Quality Indicators, quality of care

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Measures & Measurement of Healthcare Quality Poster

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: The 2017 ACR guideline for glucocorticoid-induced osteoporosis (GIOP) recommends DXA testing in patients aged ≥40 years on chronic glucocorticoids. We performed a quality improvement project to measure and improve provider adherence to this guideline in an academic adult rheumatology practice.

Methods: This project was led by adult and pediatric rheumatology fellows at our institution as part of our annual quality improvement curriculum. Our primary aim was to increase the percentage of patients aged ≥40 on prednisone with a DXA scan in the last 2 years from 15% to 30%. A secondary measure was the percentage of visits containing prednisone orders in which a DXA scan was ordered. Additional analyses were performed by patient age, sex, and ordering provider. Data were obtained with Slicer Dicer, an analytic data tool within our electronic health record (EHR), and validated by manual review of charts over a two-week period in 10/2019. Data were analyzed using descriptive statistics. We conducted these cycles using Plan-Do-Study-Act (PDSA) methodology: (1) combined pediatric and adult rheumatology grand rounds describing the project, (2) presentation on GIOP by an endocrinology expert, and (3) data feedback on DXA scan ordering rates and distribution of EHR tools for easily identifying the last DXA scan.

Results: The percentage of patients aged ≥40 on prednisone with a DXA scan in the last 2 years increased from 15.2% among patients seen in 7/2019 to a maximum of 22.9% by 12/2019 after PDSA 1, was 18.7% after PDSA 2 in 2/2020, then declined despite PDSA 3 with onset of COVID19 (Figure 1). Among all patients seen from 7/1/19 – 4/30/20 (n = 1629), the highest percentage was in women aged ≥ 65 (31.6%, n = 443), followed by women aged 40 – 65 (18.2%, n = 752), men aged ≥ 65 (16.1%, n = 211), and men aged 40 – 65 (15.7%, n = 223).

The percentage of visits containing prednisone orders in which a DXA scan was ordered increased from 8.2% in 7/2019 to a maximum of 12.4% after PDSA 2 in 2/2020, then declined with onset of COVID19 (Figure 2). Among all visits with prednisone orders from 7/1/19 – 4/30/20, DXA scan ordering rates varied among 30 providers from 0.0% – 29.2% (IQR 4.3% – 18.4%). Compared with the 2018 – 2019 academic year, DXA scan ordering rates increased among fellows throughout the project (Figure 3).

The manual chart review included 93 patients and 82 visits. Chronic prednisone use (≥ 2.5mg daily for ≥ 3 months) occurred in 65.6% of patients and 59.6% of visits. The rest were on less prednisone or only took short courses. The manual chart review also demonstrated that our search for patients with a DXA scan in the last 2 years only identified scans done at our institution; 29% of all DXA scans occurred outside our institution.

Conclusion: We have not yet met our primary aim of increasing the percentage of patients aged ≥ 40 on prednisone with a DXA scan in the last 2 years from 15% to 30%; initial improvements were negated with onset of COVID19. However, we succeeded in validating a method for tracking this data over time, enabling ongoing efforts to improve adherence to the 2017 ACR GIOP guidelines. Furthermore, the large variability in DXA scan ordering rates and substantial improvement among fellows leading this project suggest that change is possible.

Figure 1: Percentage of patients with a DXA scan in the last 2 years (line) among patients aged ≥40 on prednisone seen in rheumatology clinic each month (bars).

Figure 2: Percentage of visits with DXA scan ordered (line) among rheumatology visits with a prednisone order and patient aged ≥40 each month (bars).

Figure 3: Percentage of visits with DXA scan ordered by provider type


Disclosure: K. Kaufman, None; P. Chu, None; M. Maheswaranathan, None; A. Johannemann, None; D. Anderson, None; I. Smith, None; A. Udupa, None; M. Buckley, None; L. Cannon, None; R. Randell, Merck, 1, 2, Biogen Inc, 1; D. Leverenz, None.

To cite this abstract in AMA style:

Kaufman K, Chu P, Maheswaranathan M, Johannemann A, Anderson D, Smith I, Udupa A, Buckley M, Cannon L, Randell R, Leverenz D. A Quality Improvement Project to Improve Bone Densitometry Ordering in Adult Patients on Chronic Glucocorticoids [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/a-quality-improvement-project-to-improve-bone-densitometry-ordering-in-adult-patients-on-chronic-glucocorticoids/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-quality-improvement-project-to-improve-bone-densitometry-ordering-in-adult-patients-on-chronic-glucocorticoids/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology